FALLS CHURCH, Va. (PRWEB) April 29, 2020
It’s no secret. Artificial intelligence (AI) and robotics process automation (RPA) help manufacturers develop quality products that are safe for patients.
What are the best ways to apply AI and RPA to one’s own quality management processes (QMS) for compliance purposes? Does one know if AI and RPS can support predictive decision- making and aid in risk management strategies?
Join Christy Mazzarisi, Quality Lead at CGI, and master the latest methods for applying AI and RPA to your QMS:
- Determine how new technology such as AI and RPA decreases costs, frees up staff time for higher-value tasks and increases employee engagement
- Assess intelligent automation and how it reduces cost and increases quality and productivity
- Familiarize oneself the ways AI and RPA support capabilities for digital transformation and implementation approaches
- Gain a better understanding of what to look for within your QMS to ensure it is capturing continuous improvement initiatives such as processes and systems
- Critically evaluate what continuous improvement really means and how to apply it for inspection purposes
Use AI and RPA to improve one’s everyday production activities to ensure quality and compliance.
Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.
Continuous Quality Improvement for Pharmaceutical and
Medical Device Manufacturers:
Using Artificial Intelligence and Robotics Process Automation
An FDAnews Webinar
Wednesday, May 13, 2020 • 1:30-3:00 p.m. EDT
$287 per site
Easy Ways to Register:
By phone: 888.838.5578 or 703.538.7600
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations